Top Story
- Real World Evidence
The European Union is in charge of integrating real-world evidence (RWE) and advanced data analytics into healthcare decision-making to tackle the challenges of clinical evidence gathering in the era of rapid clinical innovation. Recognizing the limitations of traditional clinical trials, the EU has funded five projects [...]
Latest Stories
- Artificial Intelligence
- Patient Outcomes & Engagement
Featured Webinars
Beyond Accelerated Approvals: External Control Arms
Wednesday, April 10, 2024
Sponsor: Cardinal Health
Delphi Panels: What Are They Good For?
Tuesday, March 12, 2024
Sponsor: Partnership for Health Analytic Research (PHAR)
Patient Voices Matter: Transforming Industry-Sponsored Real-World Evidence with Patient-Centric Approaches
Thursday, February 29, 2024
Sponsor: Carelon Research
Integrated Evidence Generation Planning: Driving Successful Reimbursement and Life Cycle Management
Tuesday, February 27, 2024
Sponsor: OPEN Health
Handpicked Promotions & Highlights
Latest in Catalyst News powered by BioPharmCatalyst
Molecular Templates CTXR date announcement
On April 30, 2024, Citius Pharmaceuticals will announce top-line results for their recent PDUFA trial for LYMPHIR (Denileukin diftitox). The community is currently bullish on the prospects of progression, as the bulls outnumber bears by [...]
Read MoreMolecular Templates LPTX earnings announcement
Leap Therapeutics revealed their most recent quarterly earnings data, in which EPS ended up higher than estimates. EPS was reported to be -$0.46, which beat the estimated value of -$0.55. Leap Therapeutics' EPS [...]
Read MoreTango Therapeutics TNGX earnings announcement
Tango Therapeutics revealed their most recent quarterly earnings data, in which both revenue and EPS ended up lower than estimates. Revenue, at $5.43M, was the biggest surprise for the quarter, as it missed [...]
Read MoreSearch HealthEconomics.com
Throw in a keyword, research topic, disease model or technology of interest